Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials.
about
Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Adverse events across generati ...... n Phase III randomized trials.
@en
type
label
Adverse events across generati ...... n Phase III randomized trials.
@en
prefLabel
Adverse events across generati ...... n Phase III randomized trials.
@en
P2093
P2860
P356
P1476
Adverse events across generati ...... n Phase III randomized trials.
@en
P2093
Edward Chow
Florence Mok
Kenneth Li
Liying Zhang
Michael Poon
Michelle Zhou
Nicholas Lao
Urban Emmenegger
P2860
P356
10.2217/CER.12.72
P577
2013-01-01T00:00:00Z